Product Details for ANDA 074530
TERAZOSIN HYDROCHLORIDE (TERAZOSIN HYDROCHLORIDE)
EQ 1MG BASE
Marketing Status: Discontinued
EQ 2MG BASE
Marketing Status: Discontinued
EQ 5MG BASE
Marketing Status: Discontinued
EQ 10MG BASE
Marketing Status: Discontinued
EQ 1MG BASE
Marketing Status: Discontinued
Active Ingredient: TERAZOSIN HYDROCHLORIDE
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 1MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074530
Product Number: 001
Approval Date: Apr 21, 2000
Applicant Holder Full Name: IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
Marketing Status: Discontinued
Patent and Exclusivity Information
TERAZOSIN HYDROCHLORIDE (TERAZOSIN HYDROCHLORIDE)
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 1MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074530
Product Number: 001
Approval Date: Apr 21, 2000
Applicant Holder Full Name: IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 2MG BASE
Marketing Status: Discontinued
Active Ingredient: TERAZOSIN HYDROCHLORIDE
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074530
Product Number: 002
Approval Date: Apr 21, 2000
Applicant Holder Full Name: IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
Marketing Status: Discontinued
Patent and Exclusivity Information
TERAZOSIN HYDROCHLORIDE (TERAZOSIN HYDROCHLORIDE)
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074530
Product Number: 002
Approval Date: Apr 21, 2000
Applicant Holder Full Name: IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 5MG BASE
Marketing Status: Discontinued
Active Ingredient: TERAZOSIN HYDROCHLORIDE
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074530
Product Number: 003
Approval Date: Apr 21, 2000
Applicant Holder Full Name: IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
Marketing Status: Discontinued
Patent and Exclusivity Information
TERAZOSIN HYDROCHLORIDE (TERAZOSIN HYDROCHLORIDE)
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074530
Product Number: 003
Approval Date: Apr 21, 2000
Applicant Holder Full Name: IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
Marketing Status: Discontinued
Patent and Exclusivity Information
EQ 10MG BASE
Marketing Status: Discontinued
Active Ingredient: TERAZOSIN HYDROCHLORIDE
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074530
Product Number: 004
Approval Date: Apr 21, 2000
Applicant Holder Full Name: IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074530
Product Number: 004
Approval Date: Apr 21, 2000
Applicant Holder Full Name: IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
Marketing Status: Discontinued
Patent and Exclusivity Information